Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2007-06-01 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TOULON (83000), Var
PHARMACIE HURTADO SAINT ROCH : revenue, balance sheet and financial ratios
PHARMACIE HURTADO SAINT ROCH is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TOULON (83000),
this company of category PME
shows in 2024 a revenue of 2.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE HURTADO SAINT ROCH (SIREN 498820778)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
2 519 389 €
2 549 142 €
2 148 469 €
1 150 921 €
N/C
N/C
N/C
651 621 €
Net income
115 542 €
109 932 €
96 435 €
238 658 €
-141 351 €
-14 874 €
-7 218 €
-7 741 €
72 917 €
EBITDA
N/C
166 555 €
135 470 €
259 222 €
-141 535 €
-16 050 €
-11 405 €
-19 349 €
61 532 €
Net margin
N/C
4.4%
3.8%
11.1%
-12.3%
N/C
N/C
N/C
11.2%
Revenue and income statement
In 2025, PHARMACIE HURTADO SAINT ROCH generates positive net income of 116 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 73 k€ -> 116 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
115 542 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 172%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
172.058%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
34.267%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE HURTADO SAINT ROCH
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
5.768
3.757
1.85
1.972
874.262
415.95
302.169
229.161
172.058
Financial autonomy
92.879
94.896
98.029
97.101
8.97
17.538
22.967
27.828
34.267
Repayment capacity
0.966
-1.139
-0.666
-0.455
-12.373
7.717
15.94
12.441
None
Cash flow / Revenue
3.582%
None%
None%
None%
-12.403%
11.056%
3.994%
4.731%
None%
Sector positioning
Debt ratio
172.062025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of PHARMACIE HURTADO SAINT ROCH (172.06) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
34.27%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE HURTADO SAINT ROCH (34.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
12.44 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Watch
In 2024, the repayment capacity of PHARMACIE HURTADO SAINT ROCH (12.44) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 222.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
222.065
Liquidity indicators evolution PHARMACIE HURTADO SAINT ROCH
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
5669.976
6059.283
63779.232
10161.81
151.315
260.252
254.747
217.581
222.065
Interest coverage
8.414
0.0
0.0
0.0
-1.076
0.948
1.889
1.515
None
Sector positioning
Liquidity ratio
222.062025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-7 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE HURTADO SAINT ROCH (222.06) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.51x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average
In 2024, the interest coverage of PHARMACIE HURTADO SAINT ROCH (1.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE HURTADO SAINT ROCH
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
46 154 €
0 €
0 €
0 €
144 912 €
194 243 €
205 435 €
193 615 €
0 €
Inventory turnover (days)
0
0
0
0
55
38
29
29
0
Customer payment term (days)
0
0
0
0
10
3
5
6
0
Supplier payment term (days)
1
118
10
75
47
38
23
23
0
Positioning of PHARMACIE HURTADO SAINT ROCH in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE HURTADO SAINT ROCH is estimated at
1 835 398 €
(range 1 245 510€ - 2 879 992€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1245k€1835k€2879k€
1 835 398 €Range: 1 245 510€ - 2 879 992€
NAF 5 année 2025
Valuation method used
Net Income Multiple
115 542 €
×
15.9x
=1 835 398 €
Range: 1 245 510€ - 2 879 993€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE HURTADO SAINT ROCH with other companies in the same sector:
Frequently asked questions about PHARMACIE HURTADO SAINT ROCH
What is the revenue of PHARMACIE HURTADO SAINT ROCH ?
The revenue of PHARMACIE HURTADO SAINT ROCH in 2024 is 2.5 M€.
Is PHARMACIE HURTADO SAINT ROCH profitable?
Yes, PHARMACIE HURTADO SAINT ROCH generated a net profit of 116 k€ in 2025.
Where is the headquarters of PHARMACIE HURTADO SAINT ROCH ?
The headquarters of PHARMACIE HURTADO SAINT ROCH is located in TOULON (83000), in the department Var.
Where to find the tax return of PHARMACIE HURTADO SAINT ROCH ?
The tax return of PHARMACIE HURTADO SAINT ROCH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE HURTADO SAINT ROCH operate?
PHARMACIE HURTADO SAINT ROCH operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart